South Africa diphtheria cases remain under close surveillance in 2026, with health authorities continuing to monitor infections of a potentially serious but vaccine-preventable disease.
According to the National Institute for Communicable Diseases (NICD), 38 laboratory-confirmed cases of respiratory diphtheria were recorded in South Africa between 29 December 2025 and 26 July 2026. Ten asymptomatic carriers of toxigenic Corynebacterium diphtheriae were also identified.
The numbers are relatively small compared with many common infectious diseases, but diphtheria requires careful public-health attention because the infection can become severe and can spread from person to person.
For South Africans, particularly parents and carers, understanding the symptoms and the role of vaccination is more useful than reacting to the figures with unnecessary alarm.
Table of Contents
1. Where South Africa’s Diphtheria Cases Have Been Reported
The Western Cape has accounted for the majority of South Africa’s confirmed respiratory diphtheria cases during the current reporting period.
Of the 38 laboratory-confirmed cases reported by the NICD up to 26 July, 32 were from the Western Cape, representing approximately 84% of confirmed cases.
Limpopo accounted for four confirmed cases, while two were reported in Gauteng.
Health authorities had also identified 10 asymptomatic carriers of toxigenic C. diphtheriae. Eight were in the Western Cape, and two were in Limpopo.
An asymptomatic carrier has the bacteria but does not show symptoms. Identifying carriers is important because it assists health authorities with contact tracing and efforts to interrupt transmission.
2. What Is Respiratory Diphtheria?
Respiratory diphtheria is a vaccine-preventable bacterial illness primarily caused by toxin-producing strains of Corynebacterium diphtheriae.
People of any age can develop the disease.
The infection mainly affects the nose and throat, but the toxin produced by the bacteria can cause complications elsewhere in the body.
Diphtheria spreads mainly through respiratory droplets and close contact with an infected person or carrier. This is why identifying cases and tracing people who have been in close contact with them form an important part of the public-health response.
The good news is that vaccination provides an important means of protection against diphtheria.
3. Important Diphtheria Symptoms People Should Recognise
Early symptoms of respiratory diphtheria can initially resemble other throat or respiratory infections.
According to the NICD, symptoms and clinical signs can include:
- Sore throat: This can be one of the early symptoms of respiratory diphtheria.
- Low-grade fever: A person may develop a relatively mild fever despite having a potentially serious infection.
- A greyish-white membrane: A firmly attached membrane may develop in the nose, throat, tonsils or larynx. This is an important clinical feature associated with respiratory diphtheria.
- Swollen neck glands: Significant swelling can sometimes result in the characteristic appearance referred to as a “bull neck”.
- Signs of complications: Diphtheria toxin can affect organs and nerves, potentially resulting in myocarditis, neurological complications and kidney damage.
These symptoms should not be used for self-diagnosis. Several illnesses can cause sore throats, fever and swollen glands, and suspected diphtheria requires professional medical assessment.
You May Also Be Interested In: South Africa’s Worrying Measles and Rubella Outbreak in 2026
4. Why Early Treatment Matters
Diphtheria can become a medical emergency, which makes early recognition and treatment particularly important.
Clinical management may involve antibiotics to eliminate the bacteria and reduce further transmission. Diphtheria antitoxin (DAT) may also be administered to neutralise toxin that has not yet bound to body tissues.
According to NICD clinical guidance, when healthcare professionals have a strong suspicion of diphtheria, treatment, contact tracing and preventive treatment for close contacts should begin without waiting for laboratory confirmation.
This is important because early administration of diphtheria antitoxin can be lifesaving in appropriate suspected cases.
Severely affected patients may also require supportive hospital care, particularly when breathing or the airway becomes compromised.
5. Vaccination and South Africa’s Public-Health Response
One of the most important facts about diphtheria is that it is vaccine-preventable.
Vaccination against diphtheria forms part of South Africa’s routine childhood immunisation programme. Maintaining high vaccination coverage helps reduce the risk of severe disease and community transmission.
Parents and care givers who are uncertain about their child’s vaccination history should check the child’s Road to Health Booklet and speak to a healthcare professional or local clinic about whether vaccinations are up to date.
The NICD has reported that appropriate public-health responses have been initiated for suspected and confirmed cases.
These measures can include investigating suspected infections, laboratory testing, identifying close contacts, providing appropriate preventive treatment and checking vaccination histories.
6. Awareness Without Unnecessary Alarm
The continued detection of South Africa diphtheria cases deserves public-health attention, but the figures also need to be communicated responsibly.
Diphtheria is potentially serious, yet it is also a disease for which vaccination, surveillance, contact tracing and established medical treatments are available.
For ordinary South Africans, the practical message is straightforward: keep routine vaccinations up to date, know the warning signs and seek professional medical attention when diphtheria is suspected.
Continued surveillance will remain important as health authorities track infections and respond to new cases.
This article provides general health information and does not replace diagnosis, treatment, or advice from a qualified healthcare professional. To keep up with the latest updates, also read up on: Diphtheria situational report, week 32 of 2026
7. Frequently Asked Questions About Diphtheria
Is there a diphtheria outbreak in South Africa?
South Africa has recorded confirmed cases of toxigenic respiratory diphtheria during 2026, with the Western Cape accounting for most confirmed infections reported in the latest verified NICD figures used for this article.
Rather than assuming that every province faces the same level of transmission, South Africans should follow updates from the NICD and provincial health authorities.
Is diphtheria contagious?
Yes. Respiratory diphtheria can spread between people, particularly through respiratory droplets and close contact. This is why contact tracing is important when a case is suspected or confirmed.
Can adults get diphtheria?
Yes. Although childhood vaccination is extremely important, respiratory diphtheria can occur in people of all ages.
Anyone experiencing concerning symptoms or who has been identified as a close contact of a suspected or confirmed case should follow the advice provided by healthcare professionals.
Can diphtheria be treated?
Yes. Treatment can include appropriate antibiotics and, where clinically indicated, diphtheria antitoxin. Serious cases may require hospital treatment and respiratory support.
People should not attempt to treat suspected diphtheria themselves. Early professional medical assessment is important.
How can parents protect their children?
Keeping routine childhood vaccinations up to date is one of the most important protective measures.
Parents who cannot remember whether their child has received all recommended vaccinations should check the child’s vaccination record or speak to their clinic. Missing or uncertain records should be discussed with a healthcare professional rather than assuming a child is protected.
Leave a Reply